ClinicalTrials.Veeva

Menu

Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study

Yale University logo

Yale University

Status

Invitation-only

Conditions

Aortic Stenosis

Treatments

Other: AI-POCUS
Other: AI-ECG risk algorithm
Diagnostic Test: Portable 1-lead electrocardiogram
Diagnostic Test: Point-of-care ultrasound

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06749145
R01AG089981 (U.S. NIH Grant/Contract)
2000038634

Details and patient eligibility

About

The DETECT-AS Diagnostic Study will assess the performance of artificial intelligence (AI) risk predictions to detect aortic stenosis using results from portable electrocardiogram (ECG) and cardiac ultrasound devices.

Enrollment

410 estimated patients

Sex

All

Ages

70+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 70 years or older
  • Attending a routine outpatient primary care clinic at one of the three enrollment sites

Exclusion criteria

  • Opted out of research studies
  • Non-English speaking
  • Urgent or emergent visits, defined as a visit for an illness or injury that needs attention quickly or is life-threatening
  • Any echocardiogram within 12 months of clinic visit
  • Prior history of moderate or severe AS
  • Prior history of aortic valve replacement or repair, including transcatheter and surgical AVR with either a bioprosthetic or mechanical valve
  • Presence of implantable cardiac devices, including permanent cardiac pacer, implantable cardioverter-defibrillator, or left ventricular assist device
  • Prior heart transplant
  • History of dementia
  • Documented life expectancy of <1 year or current participation in hospice services.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

410 participants in 2 patient groups

Intervention
Experimental group
Description:
The intervention arm will undergo sequential screening for aortic stenosis using portable 1-lead electrocardiograms (ECGs), followed by point-of-care ultrasound (POCUS), if indicated, by artificial intelligence (AI)-based risk algorithms.
Treatment:
Diagnostic Test: Point-of-care ultrasound
Diagnostic Test: Portable 1-lead electrocardiogram
Other: AI-ECG risk algorithm
Other: AI-POCUS
Control
Sham Comparator group
Description:
The control arm will undergo a portable 1-lead electrocardiogram (ECG), with 10% randomly assigned to undergo point-of-care ultrasound (POCUS).
Treatment:
Diagnostic Test: Point-of-care ultrasound
Diagnostic Test: Portable 1-lead electrocardiogram

Trial contacts and locations

3

Loading...

Central trial contact

Rohan Khera, MD, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems